hyperalgesia
The present study suggests that an IL-1 receptor antagonist effectively attenuates or blocks long-lasting hyperalgesia and microglia activation produced by LPS exposure in the neonatal period of rats.
The present study suggests that an <span class="gene" id="20937348-9-35-39">IL-1</span> receptor antagonist effectively attenuates or blocks long-lasting <span class="disease" id="20937348-9-106-118">hyperalgesia</span> and microglia activation produced by LPS exposure in the neonatal period of rats.